Shariah compliance overview
HalalPhathom Pharmaceuticals, Inc. (PHAT) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, dedicated to advancing and commercializing therapies for gastrointestinal ailments.
Phathom Pharmaceuticals, Inc. (PHAT) operates in the Healthcare sector, in the Biotechnology industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 3.87% (limit 5%), interest-bearing debt is 27.29% (limit 30%) and interest-bearing securities and assets are 16.96% (limit 30%).
If you hold PHAT, give 3.87% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 3.87%Limit 5%Pass
- Interest-bearing debt
- 27.29%Limit 30%Pass
- Interest-bearing securities and assets
- 16.96%Limit 30%Pass
- Dividend purification
- 3.87%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Phathom Pharmaceuticals, Inc. (PHAT). Current Akinda screening label: Halal.
